113 related articles for article (PubMed ID: 2215058)
1. Effect of treatment on immune responsiveness in lepromatous leprosy patients.
Esquenazi DA; Sampaio EP; Moreira AL; Gallo ME; Almeida SM; Sarno EN
Lepr Rev; 1990 Sep; 61(3):251-7. PubMed ID: 2215058
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.
Gill HK; Ridley DS; Ganesan J; Mustafa AS; Rees RJ; Godal T
Lepr Rev; 1990 Mar; 61(1):25-31. PubMed ID: 2181222
[TBL] [Abstract][Full Text] [Related]
3. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs.
Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC
Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443
[TBL] [Abstract][Full Text] [Related]
4. Immunological profile of treated lepromatous leprosy patients.
Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763
[TBL] [Abstract][Full Text] [Related]
5. Comment: Positive Mitsuda lepromin reaction in long-term treated lepromatous leprosy and tuberculoid relapse in lepromatous leprosy.
Walter J
Lepr Rev; 1991 Dec; 62(4):434-6. PubMed ID: 1845302
[No Abstract] [Full Text] [Related]
6. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents.
Foss NT; Pagnano PM; Bechelli LM; Simoes AL
Acta Leprol; 1990; 7(2):119-28. PubMed ID: 2220296
[TBL] [Abstract][Full Text] [Related]
7. Induction of lepromin reactivity in cured lepromatous leprosy patients: impaired chemokine response dissociates protective immunity from delayed type hypersensitivity.
Mitra DK; Joshi B; Dinda AK; Rai AK; Girdhar BK; Katoch K; Bindra MS; Sengupta U
Microbes Infect; 2009 Dec; 11(14-15):1122-30. PubMed ID: 19703581
[TBL] [Abstract][Full Text] [Related]
8. Positive Mitsuda lepromin reactions in long-term treated lepromatous leprosy.
Waters MF; Ridley DS; Lucas SB
Lepr Rev; 1990 Dec; 61(4):347-52. PubMed ID: 2280656
[TBL] [Abstract][Full Text] [Related]
9. IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS.
SHEPARD CC; GUINTO RS
J Exp Med; 1963 Aug; 118(2):195-204. PubMed ID: 14074384
[TBL] [Abstract][Full Text] [Related]
10. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
Kar BR; Job CK
Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
[TBL] [Abstract][Full Text] [Related]
11. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
13. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
[TBL] [Abstract][Full Text] [Related]
14. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
16. Tuberculoid relapse in lepromatous leprosy.
Waters MF; Ridley DS
Lepr Rev; 1990 Dec; 61(4):353-65. PubMed ID: 2280657
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
19. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
Modlin RL; Mehra V; Wong L; Fujimiya Y; Chang WC; Horwitz DA; Bloom BR; Rea TH; Pattengale PK
J Immunol; 1986 Nov; 137(9):2831-4. PubMed ID: 2944966
[TBL] [Abstract][Full Text] [Related]
20. A placebo controlled clinical trial of transfer factor in lepromatous leprosy.
Faber WR; Leiker DL; Nengerman IM; Schellekens PT
Clin Exp Immunol; 1979 Jan; 35(1):45-52. PubMed ID: 371887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
